Active

Newton Biocapital II Partners

Switched

BE0767828541

Rechtspersoon Private limited company 1 establishment

Tervurenlaan 273, 1150 Sint-Pieters-Woluwe Overige financiële dienstverlening, neg

Active for

5 year, 4 months

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.

Gross margin

€ 8,285

▼ 89% vs 2024

Profit

Healthy

€ 4,082

▼ 94% vs 2024

Debts

High

€ 59,336

▼ 30% vs 2024

Newton Biocapital II Partners from Sint-Pieters-Woluwe, company number BE0767828541, closed financial year 2025 with a result of € 4,082 after tax. For that financial year Newton Biocapital II Partners recorded a gross margin of € 8,285 and equity of € -10,112. Compared with financial year 2024, the result moved from € 63,752 to € 4,082. The company is profitable. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.

What happened at Newton Biocapital II Partners?

What happened at Newton Biocapital II Partners in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 4,082 (▼ 94% vs 2024). Source: NBB ↗
  • ROAD MEDICAL GODOKAISHA S. Etr. became a director. NBB
  • BIOSS S. Etr. became a director. NBB
  • New establishment in Sint-Pieters-Woluwe. KBO
  • DANNY GONNISSEN SRL became a director. NBB
  • HEYNEN CONSULTING AG S. Etr. became a director. NBB
  • A Q INVEST SRL became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 1,776 loss in 2021 to € 4,082 profit in 2025.

Paid € 8,717 in corporate taxes since 2021.

Best year ever: 2023, with € 91,371 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Newton Biocapital II Partners? We notify you, reason included.

Follow Newton Biocapital II Partners

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

DANNY GONNISSEN SRL
HEYNEN CONSULTING AG S. Etr.
ROAD MEDICAL GODOKAISHA S. Etr.
A Q INVEST SRL
+1
Newton Biocapital II Partners
Newton Biocapital I Investment Pool
QBIC Venture Partners
Newton Biocapital Partners
+2

Behind Newton Biocapital II Partners are DANNY GONNISSEN SRL, HEYNEN CONSULTING AG S. Etr., ROAD MEDICAL GODOKAISHA S. Etr., A Q INVEST SRL and BIOSS S. Etr.. The same people are also behind Newton Biocapital I Investment Pool, QBIC Venture Partners, Newton Biocapital Partners, Ncardia Holding and DEXOWL.

See the full network in the app

Directors

According to the 2025 annual accounts

DANNY GONNISSEN SRL

Director · represented by Danny GONNISSEN

Also active at: Newton Biocapital I Investment Pool, QBIC Venture Partners

since 2021

HEYNEN CONSULTING AG S. Etr.

Director · represented by Guillaume HEYNEN

Also active at: Newton Biocapital Partners

since 2021

ROAD MEDICAL GODOKAISHA S. Etr.

Director · represented by Wada MICHIHIKO

since 2024

A Q INVEST SRL

Director · represented by Alain PARTHOENS

Also active at: Ncardia Holding, Newton Biocapital Partners, Newton Biocapital I Investment Pool +1 more

since 2021

BIOSS S. Etr.

Director · represented by Sadashi SUZUKI

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Tervurenlaan 273

1150 Sint-Pieters-Woluwe

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.

BELGIAN RISK MANAGEMENT ASSOCIATION

European Coil Coating Association

€ 877,191 revenue · 2025

FEDERATION EUROPEENNE DE RISK MANAGEMENT - FEDERATION OF EUROPEAN RISK MANAGEMENT ASSOCIATIONS

€ 3.2 million revenue · 2024

LATOUR & PETIT

€ 1.5 million gross margin · 2025

AQ PARTNERS

€ 69,850 gross margin · 2025

+16 more

Details

Company number
0767.828.541
VAT number
BE 0767.828.541
Registered office
Tervurenlaan 273, 1150 Sint-Pieters-Woluwe
Names & denominations
Newton Biocapital II Partners
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 May 2021
Peppol
Active · Active since 29 Jan 2026
Activities · NACE

Overige financiële dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What is the enterprise number of Newton Biocapital II Partners?
The enterprise number of Newton Biocapital II Partners is BE0767828541.
What is the address of Newton Biocapital II Partners?
The registered office of Newton Biocapital II Partners is located at Tervurenlaan 273, 1150 Sint-Pieters-Woluwe.
When was Newton Biocapital II Partners founded?
Newton Biocapital II Partners was founded on 4 May 2021.
What is the main activity of Newton Biocapital II Partners?
The main activity of Newton Biocapital II Partners is "Overige financiële dienstverlening, neg" (NACE code 64999).
Does Newton Biocapital II Partners have a website?
No website is currently known for Newton Biocapital II Partners.
How much profit did Newton Biocapital II Partners make in 2025?
Newton Biocapital II Partners posted a profit after taxes of € 4,082 in financial year 2025.
What is the revenue of Newton Biocapital II Partners?
As a small company, Newton Biocapital II Partners is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 8,285.
Where can I find the annual accounts of Newton Biocapital II Partners?
Newton Biocapital II Partners files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Newton Biocapital II Partners?
According to the 2025 annual accounts, the directors of Newton Biocapital II Partners are: DANNY GONNISSEN SRL, HEYNEN CONSULTING AG S. Etr., ROAD MEDICAL GODOKAISHA S. Etr., A Q INVEST SRL, BIOSS S. Etr..
Who owns Newton Biocapital II Partners?
Behind Newton Biocapital II Partners are DANNY GONNISSEN SRL, HEYNEN CONSULTING AG S. Etr., ROAD MEDICAL GODOKAISHA S. Etr., A Q INVEST SRL and BIOSS S. Etr.. The same people are also behind Newton Biocapital I Investment Pool, QBIC Venture Partners, Newton Biocapital Partners, Ncardia Holding and DEXOWL.